menu
    • menu

    Company profile for Corsair Pharma

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients. The company is focused on the development of novel prodrugs of treprostinil to treat patients with PAH using a once-daily transdermal patch.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Corsair PharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1230 Bordeaux Drive Sunnyvale, CA 94089
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.corsairpharma.com/
    Linkedin
    Linkedin
    https://linkedin.com/company/corsairpharma/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Corsair Pharma to Unveil Treprostinil Prodrug Data at PHPN 2025
    Corsair Pharma to Unveil Treprostinil Prodrug Data at PHPN 2025

    15 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250915240148/en/Corsair-Pharma-to-Present-New-Data-on-Proprietary-Treprostinil-Prodrug-Transdermal-System-at-PHPN-2025-Symposium

    BUSINESSWIRE
    15 Sep 2025
    Share Share
    Corsair Pharma Completes Preclinical Program for Treprostinil Prodrug
    Corsair Pharma Completes Preclinical Program for Treprostinil Prodrug

    17 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250312111736/en/Corsair-Pharma-Announces-Successful-Completion-of-Preclinical-Program-for-Its-Treprostinil-Prodrug-Transdermal-System

    BUSINESSWIRE
    17 Mar 2025
    Share Share
    Corsair Pharma Partners InstantGMP® to Ensure Quality for Trials
    Corsair Pharma Partners InstantGMP® to Ensure Quality for Trials

    28 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/corsair-pharma-partners-with-instantgmp-to-ensure-quality-for-clinical-trials-302361363.html

    PR NEWSWIRE
    28 Jan 2025
    Share Share
    Corsair Announces Appointment of George W. Mahaffey as Chief Executive Officer
    Corsair Announces Appointment of George W. Mahaffey as Chief Executive Officer

    11 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231211371006/en

    BUSINESSWIRE
    11 Dec 2023
    Share Share
    Corsair Pharma Announces $23 Million Series B Financing
    Corsair Pharma Announces $23 Million Series B Financing

    20 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/20/2746382/0/en/Corsair-Pharma-Announces-23-Million-Series-B-Financing-to-Advance-Clinical-Trials-in-Pulmonary-Arterial-Hypertension.html

    GLOBENEWSWIRE
    20 Sep 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search